共 50 条
- [31] Clopidogrel added to aspirin versus aspirin alone in secondary prevention and high-risk primary prevention: Rationale and design of the Clopidogrel for High Atherothrombotic Risk and Ischemic Stabilization, Management, and Avoidance (CHARISMA) trial AMERICAN HEART JOURNAL, 2004, 148 (02) : 263 - 268
- [35] High-risk acute coronary syndromes: cost-effectiveness of clopidogrel plus aspirin Nature Clinical Practice Cardiovascular Medicine, 2005, 2 (5): : 229 - 230
- [37] Cost effectiveness of aspirin, clopidogrel, or both for secondary prevention of coronary heart disease. NEW ENGLAND JOURNAL OF MEDICINE, 2002, 346 (23): : 1800 - 1806
- [40] Cost-Effectiveness Analysis of Rivaroxaban Plus Aspirin Compared with Aspirin Alone in Patients with Coronary and Peripheral Artery Diseases in Italy Clinical Drug Investigation, 2021, 41 : 459 - 468